Drug Shortage Report for RAN-ROPINIROLE

Last updated on 2022-11-25 History
Report ID 158553
Drug Identification Number 02314037
Brand name RAN-ROPINIROLE
Common or Proper name ROPINIROLE
Company Name RANBAXY PHARMACEUTICALS CANADA INC.
Market Status MARKETED
Active Ingredient(s) ROPINIROLE
Strength(s) 0.25MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100
ATC code N04BC
ATC description DOPAMINERGIC AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2022-07-06
Actual start date 2022-09-09
Estimated end date 2023-01-27
Actual end date
Shortage status Actual shortage
Updated date 2022-11-25
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 126 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v13 2022-11-25 French Compare
v12 2022-11-25 English Compare
v11 2022-11-03 French Compare
v10 2022-11-03 English Compare
v9 2022-09-10 English Compare
v8 2022-08-25 French Compare
v7 2022-08-25 English Compare
v6 2022-08-19 French Compare
v5 2022-08-19 English Compare
v4 2022-08-05 French Compare
v3 2022-08-05 English Compare
v2 2022-04-12 French Compare
v1 2022-04-12 English Compare

Showing 1 to 13 of 13